MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Psychogenic movement disorders(PMD): Treatment"

  • 2019 International Congress

    Long Term Follow Up Following Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders

    A. Kompoliti, C. Hebert, J. Behel, G. Pal, R. Kasi (Chicago, IL, USA)

    Objective: To assess the maintenance of improvement in Functional Movement Disorders (FMDs) following inpatient rehabilitation one year after discharge. Background: FMDs are chronic and challenging…
  • 2019 International Congress

    Opinions and clinical practices related to diagnosing and managing patients with functional (psychogenic) movement disorders: from 2009 to 2019

    K. Lafaver, D. Bega, M. Hallett, A. Lang, S. Lidstone, C. Maurer, F. Morgante, D. Perez, C. Stephen, J. Stone, T. Teodoro, A. Wu, A. Dwivedi, A. Espay (Louisville, KY, USA)

    Objective: (1) To examine current opinion and clinical practices related to diagnosis and management of Functional Movement Disorders (FMD); and (2) to determine if practice…
  • 2019 International Congress

    Botulinum Neurotoxin (BoNT) treatment in functional movement disorders: an extended follow up

    J. Dijk, M. Tijssen, J. Koelman, Y. Dreissen, F. Lambert (Groningen, Netherlands)

    Objective: To assess the long term effect of treatment with botulinum neurotoxin (BoNT) in patients with functional jerky or tremorous movement disorders. Background: Treatment options for…
  • 2019 International Congress

    Integrated therapy for Functional Movement Disorders: results from a pilot clinic

    S. Lidstone, L. Macgillivray, C. Marras, M. Josef, L. Muc, A. Lang (Toronto, ON, Canada)

    Objective: To create a novel pilot clinic for the treatment of Functional Movement Disorders (FMD). Background: FMDs are aberrations of motor system functioning in the…
  • 2019 International Congress

    Management of Patients with Functional Movement Disorders: A Transcultural Perspective

    C. Maurer, D. Anderson, A. Asadi-Pooya, J. Baizabal, M. Damianova, C. Ganos, R. Kanaan, M. Tijssen, J. Kwasa, I. Moreno, S. Pandey, JE. Park, D. Saylor, M. Stamelou, C. Stephen, T. Teodoro, M. Tinazzi, K. Lafaver (Stony Brook, NY, USA)

    Objective: To compare the clinical management, available resources and barriers to care for patients with functional movement disorders (FMD) across 15 countries around the globe.…
  • 2019 International Congress

    Incongruity of Functional Tremor Predicts Better Response to Transcranial Magnetic Stimulation Treatment

    N. Prezelj, K. Vogelnik, Z. Pirtošek, M. Kojović (Ljubljana, Slovenia)

    Objective: We hypothesised that patient whose functional tremor (FT) has more “voluntary” aspects may respond better to repetitive transcranial magnetic stimulation (rTMS). Background: Patients with…
  • 2019 International Congress

    rTMS-induced effects on Functional Tremor: a randomized, double-blind, controlled study

    S. Taib, F. Ory-Magne, C. Brefel-Courbon, Y. Moreau, C. Thalamas, C. Arbus, M. Simonetta-Moreau (Toulouse, France)

    Objective: To compare the effect on functional tremor (FT) of real rTMS vs sham and to test if hypnosis combined with rTMS might help to…
  • 2018 International Congress

    Neuropsychiatric disorders in observed patients with Parkinson’s disease

    S. Lukmonov, D. Tolibov (Tashkent, Uzbekistan)

    Objective: Parkinson's disease (PD), - chronic progressive disease of the brain from the degeneration of the nigrostriatal neurons in the basal ganglia and impaired function.…
  • 2017 International Congress

    Botulinum Neurotoxin (BoNT) for treatment of functional (psychogenic) jerky movement disorders: a randomized placebo-controlled clinical trial

    Y. Dreissen, J. Dijk, J. Gelauff, E. Zoons, M. Contarino, R. Zutt, B. Post, D. van Poppelen, A. Munts, J. Speelman, R. de Haan, J. Koelman, M. Tijssen (Amsterdam, Netherlands)

    Objective: To assess the effectiveness of botulinum neurotoxin (BonT) in patients with functional jerky movement disorders Background: At least 2–9% of patients seen in movement…
  • 2017 International Congress

    Treatment of Functional Neurological Disorders: Towards Expert Consensus Led Guidelines for the American Neuropsychiatric Association Committee for Research

    O. Ghaffar, M. Modirrousta, C. LaFrance, N. Williams, R. Shura, S. Ducharme, V. Voon (Whitby, ON, Canada)

    Objective: To develop evidence-based, expert consensus recommendations for the treatment of functional neurological disorders (FND) on behalf of the ANPA Committee for Research. Background: FND…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley